Literature DB >> 24224122

NFκB function and regulation in cutaneous T-cell lymphoma.

Tzu-Pei Chang1, Ivana Vancurova.   

Abstract

The nuclear accumulation and transcriptional activity of NFκB are constitutively increased in cutaneous T-cell lymphoma (CTCL) cells, and are responsible for their increased survival and proliferation. However, in addition to the anti-apoptotic and pro-inflammatory genes, NFκB induces expression of immunosuppressive genes, such as IL-10 and TGFβ, which inhibit the immune responses and are characteristic for the advanced stages of CTCL. While the mechanisms regulating NFκB-dependent transcription of anti-apoptotic and pro-inflammatory genes have been studied extensively, very little is known about the NFκB regulation of immunosuppressive genes. The specificity of NFκB-regulated responses is determined by the subunit composition of NFκB complexes recruited to the individual promoters, post-translational modifications of NFκB proteins, as well as by their interactions with other transcriptional factors and regulators. In this review, we discuss the mechanisms regulating the transcription of NFκB-dependent anti-apoptotic, pro-inflammatory and immunosuppressive genes in CTCL cells, as potential targets for CTCL therapies.

Entities:  

Keywords:  Apoptosis; IL-10; IκBα; NFκB; TGFβ; bortezomib; cutaneous T cell lymphoma; immunosuppression; proteasome inhibition

Year:  2013        PMID: 24224122      PMCID: PMC3816964     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  139 in total

1.  Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities.

Authors:  Alexander Hoffmann; Thomas H Leung; David Baltimore
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 2.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

Review 3.  Transcriptional regulation via the NF-kappaB signaling module.

Authors:  A Hoffmann; G Natoli; G Ghosh
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

4.  Bortezomib induces nuclear translocation of IκBα resulting in gene-specific suppression of NF-κB--dependent transcription and induction of apoptosis in CTCL.

Authors:  Ashish Juvekar; Subrata Manna; Sitharam Ramaswami; Tzu-Pei Chang; Hai-Yen Vu; Chandra C Ghosh; Mahmut Y Celiker; Ivana Vancurova
Journal:  Mol Cancer Res       Date:  2011-01-11       Impact factor: 5.852

5.  Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA.

Authors:  F E Chen; D B Huang; Y Q Chen; G Ghosh
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

Review 6.  The noncanonical NF-κB pathway.

Authors:  Shao-Cong Sun
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

Review 7.  Zinc status and immune system relationship: a review.

Authors:  M J Salgueiro; M Zubillaga; A Lysionek; G Cremaschi; C G Goldman; R Caro; T De Paoli; A Hager; R Weill; J Boccio
Journal:  Biol Trace Elem Res       Date:  2000-09       Impact factor: 3.738

Review 8.  Cutaneous T-cell lymphoma/leukemia.

Authors:  R S Siegel; T M Kuzel
Journal:  Curr Treat Options Oncol       Date:  2000-04

9.  Nitric oxide induces apoptosis in cutaneous T cell lymphoma (HuT-78) by downregulating constitutive NF-kappaB.

Authors:  Loveena Rishi; Rohan Dhiman; Manoj Raje; Sekhar Majumdar
Journal:  Biochim Biophys Acta       Date:  2007-05-10

Review 10.  NF-kappaB in cancer: a marked target.

Authors:  Anning Lin; Michael Karin
Journal:  Semin Cancer Biol       Date:  2003-04       Impact factor: 15.707

View more
  12 in total

1.  N-acetyl-L-cysteine sensitizes pancreatic cancers to gemcitabine by targeting the NFκB pathway.

Authors:  Suparna Qanungo; Joachim D Uys; Yefim Manevich; Anne M Distler; Brooke Shaner; Elizabeth G Hill; John J Mieyal; John J Lemasters; Danyelle M Townsend; Anna-Liisa Nieminen
Journal:  Biomed Pharmacother       Date:  2014-08-28       Impact factor: 6.529

2.  DMF: a promising therapeutic option in CTCL.

Authors:  Ivana Vancurova
Journal:  Blood       Date:  2016-08-11       Impact factor: 22.113

3.  Anti-proliferative action of IL-6R-targeted antibody tocilizumab for non-small cell lung cancer cells.

Authors:  Na-Hyun Kim; Seong-Kwan Kim; Dong-Soon Kim; Dan Zhang; Jin-A Park; Hee Yi; Jin-Suk Kim; Ho-Chul Shin
Journal:  Oncol Lett       Date:  2015-03-09       Impact factor: 2.967

4.  Bcl3 regulates pro-survival and pro-inflammatory gene expression in cutaneous T-cell lymphoma.

Authors:  Tzu-Pei Chang; Ivana Vancurova
Journal:  Biochim Biophys Acta       Date:  2014-07-30

5.  IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF).

Authors:  Andreas Willerslev-Olsen; Ivan V Litvinov; Simon M Fredholm; David L Petersen; Nina A Sibbesen; Robert Gniadecki; Qian Zhang; Charlotte M Bonefeld; Mariusz A Wasik; Carsten Geisler; Youwen Zhou; Anders Woetmann; Denis Sasseville; Thorbjørn Krejsgaard; Niels Odum
Journal:  Cell Cycle       Date:  2014-03-03       Impact factor: 4.534

6.  Targeting Cutaneous T-Cell Lymphoma Cells by Ingenol Mebutate (PEP005) Correlates with PKCδ Activation, ROS Induction as Well as Downregulation of XIAP and c-FLIP.

Authors:  Uly Sumarni; Ulrich Reidel; Jürgen Eberle
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

7.  PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma.

Authors:  Fengjie Liu; Yumei Gao; Bufang Xu; Shan Xiong; Shengguo Yi; Jingru Sun; Zhuojing Chen; Xiangjun Liu; Yingyi Li; Yuchieh Lin; Yujie Wen; Yao Qin; Shuxia Yang; Hang Li; Trilokraj Tejasvi; Lam Tsoi; Ping Tu; Xianwen Ren; Yang Wang
Journal:  Blood       Date:  2022-01-27       Impact factor: 22.113

8.  Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.

Authors:  Nina A Sibbesen; Katharina L Kopp; Ivan V Litvinov; Lars Jønson; Andreas Willerslev-Olsen; Simon Fredholm; David L Petersen; Claudia Nastasi; Thorbjørn Krejsgaard; Lise M Lindahl; Robert Gniadecki; Nigel P Mongan; Denis Sasseville; Mariusz A Wasik; Lars Iversen; Charlotte M Bonefeld; Carsten Geisler; Anders Woetmann; Niels Odum
Journal:  Oncotarget       Date:  2015-08-21

Review 9.  Why and how to investigate the role of protein phosphorylation in ZIP and ZnT zinc transporter activity and regulation.

Authors:  T E Thingholm; L Rönnstrand; P A Rosenberg
Journal:  Cell Mol Life Sci       Date:  2020-02-19       Impact factor: 9.261

10.  Novel phosphorylated TAK1 species with functional impact on NF-κB and β-catenin signaling in human Cutaneous T-cell lymphoma.

Authors:  Fernando Gallardo; Joan Bertran; Erika López-Arribillaga; Jéssica González; Silvia Menéndez; Ignacio Sánchez; Luis Colomo; Mar Iglesias; Marta Garrido; Luis Francisco Santamaría-Babí; Ferran Torres; Ramon M Pujol; Anna Bigas; Lluís Espinosa
Journal:  Leukemia       Date:  2018-02-22       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.